Searched for
MANKIND FERTILITY HORMONE
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- Semaglutide patent expiry: India’s next big public health inflection pointThe expiry of a key patent for semaglutide in India opens doors for affordable weight-loss and diabetes drugs. Indian pharmaceutical compan...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 26%With the India-Pakistan tensions cooling off and the tariff war launched by US President Trump seemingly headed for a generally acceptable ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 26%When bears go on a rampage, they don’t discriminate. So, on Monday, no matter what sector, what market cap, everything was in the red. But ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 27%As the correction continues unabated, a divergence is emerging in what is happening to the Nifty and Sensex and what is happening in the en...
- Weekly Top Picks: These large cap stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Mankind trumps EQT-ADIA to buy BSV for $1.67 bnThis is the largest acquisition by Mankind Pharma, India’s 4th largest pharma company by market share. A formal announcement regarding the ...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Mankind Pharma competes with EQT-ADIA combo for Rs 14,000 cr buyout of BSV Group from AdventThe buyout of BSV Group (formerly Bharat Serum & Vaccines Ltd) is contested by Mankind Pharma and EQT with ADIA, each offering around Rs 14...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Mankind Pharma in race with PEs to buy BSV Group at possible valuation of Rs 13,000 croreWarburg Pincus, ChrysCapital, TPG, Blackstone, EQT, Mankind Pharma, and Dr Reddy's Laboratories are competing to acquire BSV Group, a bioph...
- Stocks with tailwinds called advantage India: 5 largecap stocks from 3 different sectors with an upside potential of upto 36 %In terms of valuations and sentiment we are not far from the place where we were in the last quarter of 2023 or early part of this year. Wh...
- Global private equity firms eye $1 billion bid for Bharat Serums and vaccinesFive global private equity firms, including Warburg Pincus, Permira, EQT, Bain, and TPG, are interested in bidding for Bharat Serums and Va...
- Volatility in market is different from volatile business: 5 large cap stocks with upside potential ranging from just 2% upto 46%There cannot be any doubt about volatility on the street, both as reflected by advance decline ratio or the kind of movement we see in nift...
- Mankind setting up Rs 300-crore unit to manufacture fertility hormoneMankind is investing about ₹250-₹300 crore on the Udaipur unit that is expected to begin operations by September-October this year. The uni...
- Significant decline in sperm counts globally, including India: StudySperm count is not only an indicator of human fertility but also that of men's health, with low levels being associated with increased risk...
Load More
